Analysis of Immunophenotypic Criteria by Flow Cytometry to Define B-Cell Chronic Lymphoproliferative Diseases

Authors

  • Lacy Cardoso de Brito Junior Universidade Federal do Pará (UFPA), Instituto de Ciências Biológicas, Laboratório de Patologia Geral – Imunopatologia e Citologia. Belém (PA), Brasil. https://orcid.org/0000-0001-9102-5817
  • Maria Beatriz da Silva Fonseca Pesquisador Autônomo. Belém (PA), Brasil. https://orcid.org/0000-0001-7307-1721
  • Ana Paula Silveira Paixão Laboratório de Patologia Clínica Dr. Paulo C. Azevedo. Belém (PA), Brasil. https://orcid.org/0000-0003-3827-507X
  • Nilmara Suellen Lopes Castro Mendes Laboratório de Patologia Clínica Dr. Paulo C. Azevedo. Belém (PA), Brasil. https://orcid.org/0000-0001-6170-8289
  • Jessica Sabrina Cordeiro Parente Fundação Centro de Hemoterapia e Hematologia do Pará (Hemopa). Belém (PA), Brasil. https://orcid.org/0000-0002-4706-4103
  • Matheus Holanda Nascimento UFPA. Laboratório de Patologia Clínica Dr. Paulo C. Azevedo. Belém (PA), Brasil. https://orcid.org/0000-0001-9351-2918

DOI:

https://doi.org/10.32635/2176-9745.RBC.2023v69n1.2734

Keywords:

lymphoproliferative disorders/diagnosis, immunophenotyping, flow cytometry

Abstract

Introduction: Flow cytometry is an important methodology for the diagnosis of chronic B-cell lymphoproliferative diseases (CBCLPD), however, sometimes the cytometrist does not find sufficient elements for the exact definition of the pathological entity involved. Objective: To analyze the reports issued to patients with chronic lymphoproliferative diseases (CLPD) tested at a private laboratory in Belém-PA, according to the classification criteria established by the studies by Matutes et al. and Craig and Foon. Method: Retrospective study with reports of patients who underwent immunophenotyping by flow cytometry for the diagnosis of CBCLPD from September 2015 to December 2019. Results: After applying the criteria by Matutes et al. and Craig and Foon to the reports analyzed, agreement was reached for 45.24% of the cases of chronic b-cell lymphocytic leukemia/small B-cell lymphocytic lymphoma, 14.29% of the cases of follicular lymphoma, 4.76% of the cases of hairy cell leukemia and 21.43% of the cases defined as “other CBCLPDs not classifiable by flow cytometry”. However, Hotelling’s hypothesis test (p=0.0409) showed a statistical difference for the definition of CBCLPD according to the criteria adopted. Conclusion: The results emphasize that even though flow cytometry is important for the characterization of CBCLPD, sometimes the cytometrist needs to include the category “other chronic B-cell lymphoproliferative diseases not classified by flow cytometry” in the report to induce the prescriber to request additional complementary exams.

Downloads

Download data is not yet available.

References

Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Vol. 2. Lyon (France): International Agency for Research on Cancer (IARC); 2008.

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. doi: https://doi.org/10.1182/blood-2016-01-643569 DOI: https://doi.org/10.1182/blood-2016-01-643569

Gaidano V, Tenace V, Santoro N, et al. A clinically applicable approach to the classification of B-Cell non-Hodgkin lymphomas with flow cytometry and machine learning. Cancers (Basel). 2020;12(6):1684. doi: https://doi.org/10.3390/cancers12061684 DOI: https://doi.org/10.3390/cancers12061684

Boyd SD, Natkunam Y, Allen JR, et al. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results. Appl Immunohistochem Mol Morphol. 2013;21(2):116-31. doi: https://doi.org/10.1097/PAI.0b013e31825d550a DOI: https://doi.org/10.1097/PAI.0b013e31825d550a

Davis BH, Holden JT, Bene MC, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom. 2007;72B(S1):S5-13. doi: https://doi.org/10.1002/cyto.b.20365 DOI: https://doi.org/10.1002/cyto.b.20365

Tute RM. Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies. Histopathology. 2011;58(1):90-105. doi: https://doi.org/10.1111/j.1365-2559.2010.03703.x DOI: https://doi.org/10.1111/j.1365-2559.2010.03703.x

van Dongen JJM, Lhermitte L, Böttcher S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908-75. doi: https://doi.org/10.1038/leu.2012.120 DOI: https://doi.org/10.1038/leu.2012.120

Glynn E, Soma L, Wu D, et al. Flow cytometry for non-Hodgkin and Hodgkin lymphomas. Methods Mol Biol. 2019;1956:35-60. doi: https://doi.org/10.1007/978-1-4939-9151-8_2 DOI: https://doi.org/10.1007/978-1-4939-9151-8_2

Böttcher S, Engelmann R, Grigore G, et al. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Adv. 2022;6(3):976-92. doi: https://doi.org/10.1182/bloodadvances.2021005725 DOI: https://doi.org/10.1182/bloodadvances.2021005725

Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) harmonisation project. Cytometry B Clin Cytom. 2018;94(1):121-8. doi: https://doi.org/10.1002/cyto.b.21595 DOI: https://doi.org/10.1002/cyto.b.21595

Zhao M, Mallesh N, Höllein A, et al. Hematologist-level classification of mature B-cell Neoplasm using deep learning on multiparameter flow cytometry data. Cytometry A. 2020;97(10):1073-80. doi: https://doi.org/10.1002/cyto.a.24159 DOI: https://doi.org/10.1002/cyto.a.24159

Brito Junior LC, Feio DCA, Barbosa SR, et al. Diagnóstico de imunofenótipos de síndromes linfoproliferativas crônicas por citometria de fluxo na Fundação HEMOPA. J Bras Patol Med Lab. 2011;47(6):607-10. https://doi.org/10.1590/S1676-24442011000600006 DOI: https://doi.org/10.1590/S1676-24442011000600006

Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8(10):1640-5. Cited in: PubMed; PMID 7523797.

Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941-67. doi: https://doi.org/10.1182/blood-2007-11-120535 DOI: https://doi.org/10.1182/blood-2007-11-120535

Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.

Bezerra AMPS, Pasqualin C, Guerra JCC, et al. Correlation between flow cytometry and histologic findings: ten year experience in the investigation of lymphoproliferative diseases. Einstein (São Paulo). 2011;9(2):151-9. doi: https://doi.org/10.1590/S1679-45082011AO2027 DOI: https://doi.org/10.1590/s1679-45082011ao2027

Hoffmann J, Rother M, Kaiser U, et al. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping. Cytometry B Clin Cytom. 2020;98(6):476-82. doi: https://doi.org/10.1002/cyto.b.21936 DOI: https://doi.org/10.1002/cyto.b.21936

Downloads

Published

2023-01-16

How to Cite

1.
Brito Junior LC de, Fonseca MB da S, Paixão APS, Mendes NSLC, Parente JSC, Nascimento MH. Analysis of Immunophenotypic Criteria by Flow Cytometry to Define B-Cell Chronic Lymphoproliferative Diseases. Rev. Bras. Cancerol. [Internet]. 2023 Jan. 16 [cited 2024 Dec. 23];69(1):e-072734. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/2734

Issue

Vol. 69 No. 1 (2023): Jan./Feb./Mar.

Section

ORIGINAL ARTICLE

License

Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)